Torti Frank — SEC Form 4 filings
SEC reporting owner CIK 1647805. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-04 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 3,000,000 shares, $82,039,460 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 1,400,000 shares @ $27.42 ($38,388,000) in Roivant Sciences Ltd., filed 2026-02-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | President and Vant Chair | 5 | — | 3 legs · 3,000,000 sh · $82,039,460 | 13 |
| Immunovant, Inc. (IMVT) | Director | 3 | — | — | 6 |
| Arbutus Biopharma Corp (ABUS) | Director | 1 | — | — | 1 |
Form 4 filings — Torti Frank
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 40,310 @ $35.39 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 174,189 @ $0 · Grant/award (A): 88,325 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 160,035 @ $27.70 | EDGAR |
| 2026-02-23 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 1,400,000 @ $3.85 · Sale (S): 1,400,000 @ $27.42 · Option exercise (M): 1,012,610 @ $3.85 · Sale (S): 1,012,610 @ $27.15 · Option exercise (M): 587,390 @ $3.85 · Sale (S): 587,390 @ $27.51 · +3 more | EDGAR |
| 2025-12-29 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 175,380 @ $22.45 · Other (J): 64,891 @ $22.47 · Gift (G): 110,489 @ $0 | EDGAR |
| 2025-08-01 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 1,836,547 @ $0 · Grant/award (A): 11,900,000 @ $0 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 199,365 @ $0 · Grant/award (A): 93,599 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Arbutus Biopharma Corp (ABUS) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 120,400 @ $0 · Grant/award (A): 50,167 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →